Patricia V. Email & Phone Number

Washington Dc-Baltimore Area

Washington Metro Area

Chevy Chase, Maryland, United States

The American Health Systems Engineering Association ® is a network community committed to the vision of a world where systems engineering can transform healthcare processes, its delivery and ultimately people’s care. It is the professional home for the health systems engineers of today and the driver of health systems engineering’s future. Through education, training, accreditation, and certification, AHSEA supports the current and next generation of health systems engineer professionals.

New York, New York

Health and Human Services Policies and Regulations▪ Capital and Investments: Advised healthcare, drug industries, and Federal gov’t on policies and regulation on health care informatics and systems engineering concepts; increased transparency, predictability, and accountability by 90%-100%; empowered administrators and boards to make informed investments decisions.

New York, New York

▪ Healthcare IT Market Trends: Advised on healthcare information technology market trends, new health data analytics products, technologies, cross-selling, regulations, and competitive environments qualitative and quantitative data analysis in biotechnology, pharmaceutical, and managed care industries; increased transparency, predictability, and accountability by 90%-100%; empowered administrators and boards to make prudent capital and investments decisions.

Bethesda, Maryland

Proposal Development Advisor, Center for Medicare and Medicaid Services Innovation Center▪ Health Data Registry: Advised on Health Data Registry capabilities to fulfill RFP task requirements; improved RFP task requirements content by 100%.▪ Proposal Development: Streamlined proposal development by 100% with Subject Matter Expert (SME) outside perspective, insight, and expertise.

Baltimore, Maryland

▪ Quality Improvement: Contributed to continuous quality improvement support for Information Technology and operational solutions delivery on large projects and programs for Center for Medicare and Medicaid Innovation (CMMI) by testing, evaluating, and expanding innovative non-claims payment and claims payment solutions:▪ Patient Experience: Streamlined information technology processes by 80% to mitigate healthcare costs, improved customer experience, and service delivery models.▪ Patient Outcomes: Streamlined information technology processes by 85%, improving patient and population health outcomes/clinical performance measures for healthcare organizations.▪ Healthcare IT: Directed strategic Healthcare Information Technology data-driven projects with competitive analysis for teams, including solution development improvements and intuitive, seamless workflow design and product roadmap; expanded value-based payment model design effectiveness by 50%.▪ Program Evaluation: Evaluated Innovative Payment Contractor developed by Business Services Group for CMMI to execute qualitative analysis of all data involved; streamlined program development by 90%.▪ Qualitative Analysis: Executed qualitative analysis on value-based payment model applications and Medicare payment program evaluation and integrity; lifted overall program evaluation process by 100%.▪ Artificial Intelligence: Recommended different artificial intelligence platforms and data science tools for healthcare data analysis; designed health data registry concept; elevated awareness of artificial intelligence platforms and data science tools for healthcare claims data analysis by 75%.▪ Data Analytics: Executed data structure analysis, driving data analytics insights, and developing analytical solutions for health data registry, a data analytics solution concept; increased request for proposal inclusion of artificial intelligence platforms and data science tools for healthcare claims data analysis tasks by 100%.

▪ B2B2C Strategic Model: Designed and implemented strategic model, marketing health data analytics cloud products to Fortune 500 companies in self-insured health plans market; unlocked new users’ market for company’s offerings by 70%.▪ Solutions Value Proposition: Collaborated with cross-functional teams, expanding product and solution offerings value proposition, and new paying customers market segment by 80%.▪ Data-driven Decisions: Executed strategic decision-making plans for cost containment, return on investment, product value proposition, risk analyses, and unit effectiveness, improving annual revenues by 85%.▪ Product Quality: Improved product quality with subject-matter insights on healthcare environment workflows; upgraded health care claims data analysis, data reporting, process improvement, and claims reimbursement by 90%.

Chantilly, Virginia

▪ Business Development: Designed strategic business development action plans by establishing partnership agreements with Johns Hopkins University; won $20 billion CIOSP3 RFP contract award.

Rockville, Maryland

▪ Contract Rebid Award: Implemented strategic business development action plans, thereby winning $67 million HHS NCI Enterprise System RFP contract re-bid award.

▪ Business Development: Executed strategic business development action plans; won Federal blanket purchase agreement, providing customers vendor discounts, pre-negotiated terms and conditions, administrative burdens and cost reductions, streamlined ordering procedures, and reduced procurement lead time.

Frederick, Md

Washington, District Of Columbia

▪ Successfully designed, implemented and managed a Clinical Trial Electronic Medical Record a Point of Care Relational Database for the Department of Gastroenterology Hepatitis C Population Health Management - a joint effort with the Department of Clinical Investigation. These databases allowed for data aggregation from paper health records, practice management systems, pharmacies, labs providing a savings totaling $48,000 to the Department of Clinical Investigation. Moreover, it helped the department to manage their Hepatitis C populations by promoting evidence-based care, track individual patients and get data on clinical events and lab results; it provided compliance reports to identify patients who needed screenings or other care to better coordinate and close gaps in patient care.▪ Implemented and managed Clinical Research Trial programs sponsored by pharmaceutical companies such as ROCHE and SciClone Inc. providing operational and quality assurance oversight according to the Food and Drug Administration, International Clinical Harmonization, Good Clinical Practices, and local Institutional Review Board rules, regulations and policy requirements for healthcare organizations.▪ Implemented and managed epidemiological studies in the WRAMC Liver Clinic, Gastroenterology Service by planning, coordinating, conducting, analyzing, interpreting, and publishing scientific data. Reviewed, evaluated, analyzed, and published clinical data using different statistical applications including SPSS v.10. ▪ Acted as a liaison between ROCHE and SciClone Inc., Regulatory Affairs Division of Clinical Research Management companies such as AAI International and the Department of Clinical Investigation Internal Review Board Committee providing for effective control of financial loss for all stakeholders involved. ▪ Managed clinical research trial personnel by providing leadership and direction to the Liver Clinic support staff, Gastroenterology Fellows.

Washington, District Of Columbia

Department of Clinical Investigation▪ Hepatitis C Virus Infection: Mechanism of Disease Progression – WU # 01-92003, Peer Reviewed Medical Research Program (PRMRP) Supplement to the US Army Medical Research and Material Command (USAMRMC), Department of Defense. ▪ A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety Study of Pegasys® vs. Pegasys® Plus Ribavirin Treatment vs. a Twelve-Week Treatment Delay in Patients with Chronic Hepatitis C – WU# 01-92002, ROCHE Protocol #NR16161 ▪ Thymosin alpha 1 and Pegasys Interferon Combination Therapy in Chronic Hepatitis C. SciClone Protocol #NR0804

Bethesda, Md

Projects:+ Determination of Neutralizing Response to VEE-HIV env Replicons. NIH Extramural Program, Grant Number: 1R21AI44339-01)+ The Role of Dendritic Cells in VEE Pathogenesis, a molecular approach: Fogarty International Center, NIH Grant Number: 5D43TW00916-02 and USUHS Intramural Program).

Minas Gerais, Brazil

▪ Directed program efforts to establish and implement basic science research guidelines. I evaluated research program activities with respect to long-range objectives and made recommendations concerning areas of the program requiring emphasis to achieve the department’s long-range objectives. ▪ Recommended techniques and methods for increasing the effectiveness of the program, and of the new scientific and professional developments that warranted, permitted, and necessitated changes. ▪ Assisted in the formulation and planning of the Obstetrics and Gynecology Department intramural and extramural research program objectives and policies. I advised the department chair and professors on scientific program decision-making issues.

Brazil

▪ Advised on program efforts to establish and implement research guidelines for genetic product and services. I planned and established a molecular biology laboratory structure for the execution of genetic services. ▪ Assisted in budget analysis, estimates calculation required to formulate a budget necessary to meet the needs of the company’s product and services.

Bethesda, Md

Laboratory of Dr. D. Carleton Gajdusek, shared the 1976 Nobel Prize in Physiology or Medicine with Dr. Baruch S. Blumberg, of the Institute for Cancer Research in Philadelphia.

San Francisco, California

▪ Managed pathology studies related to the transmission of HIV infection from mother to fetus. The understanding of the HIV/AIDS pathogenic mechanisms correlates to the optimization of a HIV vaccine design in the future. The knowledge obtained from this work is significant to the fact of envision alternative approaches to HIV vaccine design and its effectiveness.

New York, New York

Perinatal Center, Department of Obstetrics and GynecologyWomen and Infants AIDS Transmission Study, NIH funded.+ “Epidemiological Survey of HIV-1 Seropositive Pregnant Women Population Attending the Perinatal Center and the Obstetrics Clinic at the Columbia-Presbyterian Medical Center”+ “In situ Hybridization of HIV-1 Infected Placental Cells”

Master Of Health Systems Engineering

Master Of Business Administration (Mba)

Master Of Business Administration (Mba)

Master Of Science

Doctor Of Medicine (Md)

Doctor Of Medicine (Md)